Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elutia Inc. stock logo
ELUT
Elutia
$0.85
+3.8%
$0.82
$0.50
▼
$1.39
$36.45M0.9376,741 shs49,310 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$2.06
-1.0%
$3.45
$1.63
▼
$5.25
$10.34M1.891,864 shs17,544 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.65
+8.3%
$0.62
$0.43
▼
$2.17
$30.22M0.92173,700 shs495,653 shs
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$1.09
-5.2%
$1.15
$0.28
▼
$3.85
$41.34M3.974.08 million shs2.54 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elutia Inc. stock logo
ELUT
Elutia
+3.77%-8.47%+7.54%-7.51%+16.92%
HeartSciences Inc. stock logo
HSCS
HeartSciences
-0.96%-13.81%-31.79%-19.22%-31.10%
InspireMD, Inc. stock logo
NSPR
InspireMD
+8.33%-16.67%+42.79%-28.56%-67.66%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
-5.22%+6.86%-27.33%-2.68%+108,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elutia Inc. stock logo
ELUT
Elutia
$0.85
+3.8%
$0.82
$0.50
▼
$1.39
$36.45M0.9376,741 shs49,310 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$2.06
-1.0%
$3.45
$1.63
▼
$5.25
$10.34M1.891,864 shs17,544 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.65
+8.3%
$0.62
$0.43
▼
$2.17
$30.22M0.92173,700 shs495,653 shs
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$1.09
-5.2%
$1.15
$0.28
▼
$3.85
$41.34M3.974.08 million shs2.54 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elutia Inc. stock logo
ELUT
Elutia
+3.77%-8.47%+7.54%-7.51%+16.92%
HeartSciences Inc. stock logo
HSCS
HeartSciences
-0.96%-13.81%-31.79%-19.22%-31.10%
InspireMD, Inc. stock logo
NSPR
InspireMD
+8.33%-16.67%+42.79%-28.56%-67.66%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
-5.22%+6.86%-27.33%-2.68%+108,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elutia Inc. stock logo
ELUT
Elutia
1.00
SellN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
2.00
Hold$8.00288.35% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50592.31% Upside
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest HSCS, ELUT, NSPR, and QTEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
DowngradeSell (D-) ➝ Sell (E+)
10/8/2026
Elutia Inc. stock logo
ELUT
Elutia
DowngradeSell (D) ➝ Sell (E+)
9/25/2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
UpgradeSell (E+) ➝ Sell (D-)
9/21/2026
HeartSciences Inc. stock logo
HSCS
HeartSciences
Reiterated RatingSell (E+)
8/24/2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
Reiterated RatingSell (E+)
8/18/2026
Elutia Inc. stock logo
ELUT
Elutia
DowngradeSell (D+) ➝ Sell (D)
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elutia Inc. stock logo
ELUT
Elutia
$12.29M3.08N/AN/A$0.35 per share2.44
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/A$0.07 per shareN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.84M2.79N/AN/A$1.83 per share0.36
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
$290K135.12N/AN/A$0.06 per share18.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elutia Inc. stock logo
ELUT
Elutia
$53.38M$1.110.77N/AN/A546.70%-140.53%-54.54%N/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$9.14M-$3.22N/AN/AN/AN/A-816.90%-181.97%12/21/2026 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.59N/AN/AN/A-413.96%-69.42%-57.68%N/A
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
-$13.22MN/AN/AN/AN/AN/AN/AN/AN/A

Latest HSCS, ELUT, NSPR, and QTEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Elutia Inc. stock logo
ELUT
Elutia
-$0.15-$0.04+$0.11-$0.04$1.00 million$1.14 million
9/24/2026Q2 2026
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
N/A-$0.07N/A-$0.07N/A$0.78 million
9/14/2026Q1 2027
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$0.72-$0.86-$0.14-$0.86$0.10 million$0.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elutia Inc. stock logo
ELUT
Elutia
N/AN/AN/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elutia Inc. stock logo
ELUT
Elutia
0.53
2.63
2.61
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/A
0.14
0.07
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
0.12
2.00
1.62

Institutional Ownership

CompanyInstitutional Ownership
Elutia Inc. stock logo
ELUT
Elutia
74.03%
HeartSciences Inc. stock logo
HSCS
HeartSciences
17.24%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
12.72%

Insider Ownership

CompanyInsider Ownership
Elutia Inc. stock logo
ELUT
Elutia
17.80%
HeartSciences Inc. stock logo
HSCS
HeartSciences
4.90%
InspireMD, Inc. stock logo
NSPR
InspireMD
24.98%
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
29.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elutia Inc. stock logo
ELUT
Elutia
2644.29 million36.41 millionNot Optionable
HeartSciences Inc. stock logo
HSCS
HeartSciences
144.97 million4.73 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
12746.49 million18.33 millionOptionable
QTREX Quantum Ltd. stock logo
QTEX
QTREX Quantum
4135.95 million25.38 millionN/A

Recent News About These Companies

QTREX Quantum Ltd. Ordinary Shares (QTEX) Earnings
QTREX Quantum Ltd. (QTEX)
Correction: QTREX Quantum Announces Clean Capital Structure
QTREX Quantum Announces Clean Capital Structure
QTREX receives Nasdaq non-compliance notice
QTREX Quantum Stock Climbs Friday: What's Going On?
QTREX Quantum Reports First Half 2026 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Elutia stock logo

Elutia NASDAQ:ELUT

$0.85 +0.03 (+3.77%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.85 0.00 (-0.34%)
As of 09:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

HeartSciences stock logo

HeartSciences NASDAQ:HSCS

$2.06 -0.02 (-0.96%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$2.24 +0.18 (+8.79%)
As of 07:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

InspireMD stock logo

InspireMD NYSE:NSPR

$0.65 +0.05 (+8.33%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.64 -0.01 (-2.00%)
As of 09:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

QTREX Quantum stock logo

QTREX Quantum NASDAQ:QTEX

$1.09 -0.06 (-5.22%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$1.10 +0.01 (+1.38%)
As of 09:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.